Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models

Péter Farkas, Franciska Könczöl, D. Lőrinczy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Lots of cytotoxic drug have cardiac toxic effect, but besides some other drugs, cyclophosphamide has got a similar cardiac toxic effect but its mechanism less clear. Limit value of cyclophosphamide which causes severe cardiac toxicity is also not known. The purpose of this study was to introduce at the first time the calorimetry in the diagnosis of cyclophosphamide-induced cardiomyopathy in an experimental animal model and to try to assign a limit value of cyclophosphamide which can cause cardiac muscle damage. Adult guinea pigs (n = 55, in 11 different groups) were injected intraperitoneally with the dose of cyclophosphamide that comparable to the human dosage. Animals were euthanized; left ventricle cardiac muscle samples were analysed by a SETARAM micro-calorimeter. The denaturation temperatures were measured, and the calorimetric enthalpies were calculated based on the areas under thermal absorption curves. The thermal parameters of denaturation of the samples show that several times administered cyclophosphamide can damage myosin head and actin first, and with increasing dose the full actomyosin complex gets damaged. With the results of our study, we can get closer to understand the pathophysiology and get more data about of the limit value of cyclophosphamide-induced cardiomyopathy.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalJournal of Thermal Analysis and Calorimetry
DOIs
Publication statusAccepted/In press - Feb 9 2016

Fingerprint

animal models
Cyclophosphamide
Animals
examination
biopolymer denaturation
muscles
damage
dosage
cardiac ventricles
drugs
thermal absorption
myosins
guinea pigs
causes
Denaturation
Poisons
toxicity
calorimeters
animals
heat measurement

Keywords

  • Cyclophosphamide
  • DSC
  • Left ventricle
  • Polyneuropathy

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Condensed Matter Physics

Cite this

Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models. / Farkas, Péter; Könczöl, Franciska; Lőrinczy, D.

In: Journal of Thermal Analysis and Calorimetry, 09.02.2016, p. 1-5.

Research output: Contribution to journalArticle

@article{5ab86e37c3a84794b72fa957f27a6bf3,
title = "Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models",
abstract = "Lots of cytotoxic drug have cardiac toxic effect, but besides some other drugs, cyclophosphamide has got a similar cardiac toxic effect but its mechanism less clear. Limit value of cyclophosphamide which causes severe cardiac toxicity is also not known. The purpose of this study was to introduce at the first time the calorimetry in the diagnosis of cyclophosphamide-induced cardiomyopathy in an experimental animal model and to try to assign a limit value of cyclophosphamide which can cause cardiac muscle damage. Adult guinea pigs (n = 55, in 11 different groups) were injected intraperitoneally with the dose of cyclophosphamide that comparable to the human dosage. Animals were euthanized; left ventricle cardiac muscle samples were analysed by a SETARAM micro-calorimeter. The denaturation temperatures were measured, and the calorimetric enthalpies were calculated based on the areas under thermal absorption curves. The thermal parameters of denaturation of the samples show that several times administered cyclophosphamide can damage myosin head and actin first, and with increasing dose the full actomyosin complex gets damaged. With the results of our study, we can get closer to understand the pathophysiology and get more data about of the limit value of cyclophosphamide-induced cardiomyopathy.",
keywords = "Cyclophosphamide, DSC, Left ventricle, Polyneuropathy",
author = "P{\'e}ter Farkas and Franciska K{\"o}ncz{\"o}l and D. Lőrinczy",
year = "2016",
month = "2",
day = "9",
doi = "10.1007/s10973-016-5294-0",
language = "English",
pages = "1--5",
journal = "Journal of Thermal Analysis and Calorimetry",
issn = "1388-6150",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models

AU - Farkas, Péter

AU - Könczöl, Franciska

AU - Lőrinczy, D.

PY - 2016/2/9

Y1 - 2016/2/9

N2 - Lots of cytotoxic drug have cardiac toxic effect, but besides some other drugs, cyclophosphamide has got a similar cardiac toxic effect but its mechanism less clear. Limit value of cyclophosphamide which causes severe cardiac toxicity is also not known. The purpose of this study was to introduce at the first time the calorimetry in the diagnosis of cyclophosphamide-induced cardiomyopathy in an experimental animal model and to try to assign a limit value of cyclophosphamide which can cause cardiac muscle damage. Adult guinea pigs (n = 55, in 11 different groups) were injected intraperitoneally with the dose of cyclophosphamide that comparable to the human dosage. Animals were euthanized; left ventricle cardiac muscle samples were analysed by a SETARAM micro-calorimeter. The denaturation temperatures were measured, and the calorimetric enthalpies were calculated based on the areas under thermal absorption curves. The thermal parameters of denaturation of the samples show that several times administered cyclophosphamide can damage myosin head and actin first, and with increasing dose the full actomyosin complex gets damaged. With the results of our study, we can get closer to understand the pathophysiology and get more data about of the limit value of cyclophosphamide-induced cardiomyopathy.

AB - Lots of cytotoxic drug have cardiac toxic effect, but besides some other drugs, cyclophosphamide has got a similar cardiac toxic effect but its mechanism less clear. Limit value of cyclophosphamide which causes severe cardiac toxicity is also not known. The purpose of this study was to introduce at the first time the calorimetry in the diagnosis of cyclophosphamide-induced cardiomyopathy in an experimental animal model and to try to assign a limit value of cyclophosphamide which can cause cardiac muscle damage. Adult guinea pigs (n = 55, in 11 different groups) were injected intraperitoneally with the dose of cyclophosphamide that comparable to the human dosage. Animals were euthanized; left ventricle cardiac muscle samples were analysed by a SETARAM micro-calorimeter. The denaturation temperatures were measured, and the calorimetric enthalpies were calculated based on the areas under thermal absorption curves. The thermal parameters of denaturation of the samples show that several times administered cyclophosphamide can damage myosin head and actin first, and with increasing dose the full actomyosin complex gets damaged. With the results of our study, we can get closer to understand the pathophysiology and get more data about of the limit value of cyclophosphamide-induced cardiomyopathy.

KW - Cyclophosphamide

KW - DSC

KW - Left ventricle

KW - Polyneuropathy

UR - http://www.scopus.com/inward/record.url?scp=84957698780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957698780&partnerID=8YFLogxK

U2 - 10.1007/s10973-016-5294-0

DO - 10.1007/s10973-016-5294-0

M3 - Article

AN - SCOPUS:84957698780

SP - 1

EP - 5

JO - Journal of Thermal Analysis and Calorimetry

JF - Journal of Thermal Analysis and Calorimetry

SN - 1388-6150

ER -